Intra-ImmuSG seeks to develop a safer and more effective cancer therapy via a combination of a targeted therapy and immunotherapy.

AI creates anti-cancer molecules for proteins that previously could not be targeted pharmacologically by leveraging quantum ...

Breast cancers can be classified into subgroups that hint at the aggressiveness of the cancer and the likelihood that the ...

The new study adds to growing evidence that measuring activated proteins is key to cancer therapy selection.Golden, CO, Feb. 10, 2025 (GLOBE ...

CRISPR technology has radically transformed genetic research, and at the forefront of this transformation is CRISPR screening ...

Global Personalized Medicine Market size is expected to be worth around USD 1,103.6 Bn by 2032 from USD 553.8 Bn in 2023, growing at a CAGR of 8.2% ...

A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research led by investigators at the Johns Hopkins Kimmel ...

For all of last year, Illumina’s net loss grew 5% from $1.161 billion to $1.223 billion, on revenue that fell 3% from $4.505 ...

Know about the revolutionary therapies, personalised medicine and cancer treatments that are changing the game!

Precision oncology is a cancer treatment approach that considers individual genetics, environmental exposures, and lifestyle factors to tailor the most ...

The BC Cancer Foundation is launching a fundraising campaign to support the next three years of immunotherapy research at BC ...